All Peter Doherty Institute for Infection and Immunity articles
-
News‘Low risk’ antibiotic has led to an almost untreatable superbug
A new study has found that an antibiotic for liver disease patients could expose them to greater risk of a dangerous superbug.
-
NewsStudy sheds light on how virus-fighting cells develop during long Covid
A new long-term study into long COVID has investigated how a certain population of white blood cells, called memory T cells, are established and develop as part of the body’s defense to fight off the disease.
-
NewsCOVID-19 vaccine candidates show robust boosting potential
Two COVID-19 vaccines have shown strong potential to be an improved approach for boosting immunity to SARS-CoV-2 variants according to interim results of a Phase 1 clinical trial.
-
NewsResearchers discover genes behind AMR in deadly superbug infections
Australian researchers have uncovered new genetic insights into Staphylococcus aureus, revealing what makes the bacterium so dangerous when it enters the blood.
-
NewsInflammation slows malaria parasite growth and reproduction in the body
Researchers have found that inflammation in the body can slow down the development of malaria parasites in the bloodstream.
-
NewsBreakthrough harnesses mRNA technology to develop malaria vaccine
A new mRNA vaccine targeting immune cells in the liver could be the key to tackling malaria, a disease that causes over half a million deaths each year, yet has no effective long-lasting vaccine.
-
NewsMicrobiologist and virologist creating Global Pandemic Research Alliance
Columbia University virologist Professor David Ho and The University of Hong Kong (HKU) microbiologist Professor Kwok-yung Yuen are teaming up to create a global alliance for conducting research in emerging infectious diseases.
-
NewsBacteria discreetly living in throat are primary source of Strep A transmission
Breakthrough research has found that Group A Streptococcus (GAS) infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of infection.
